Maricopa Medical Center
Phoenix, Arizona, United States
Medical center in Phoenix, Arizona
2601 E Roosevelt St, Phoenix, AZ 85008
About Maricopa Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Atox Bio Ltd
2
Cumberland Pharmaceuticals
2
Eli Lilly and Company
2
Instituto Bioclon S.A. de C.V.
2
MedImmune LLC
2
MediWound Ltd
2
Pharmacia
2
University of Massachusetts, Worcester
2
University of Pittsburgh
2
3M
1
Allergan
1
Clinical Trials at Maricopa Medical Center
During the past decade, Maricopa Medical Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 13 clinical trials were completed, i.e. on
average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
Completed
200
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Completed
250
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Completed
750
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
2002-05-01
2003-05-01
Completed
354
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
2002-08-01
2003-08-01
Completed
204
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
2002-03-01
2004-01-01
Completed
40
Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor
2006-04-01
2007-08-01
Completed
1,308
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Maricopa Medical Center" #1 sponsor was "Atox Bio Ltd" with 2 trials, followed by "Cumberland Pharmaceuticals" with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Instituto Bioclon S.A. de C.V." with 2 trials sponsored and "MedImmune LLC"
with 2 trials sponsored. Other sponsors include 30 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Maricopa Medical Center"
#1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of General Medical Sciences (NIGMS)" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were
collaborators in the rest 32 trials.
Clinical Trials Conditions at Maricopa Medical Center
According to Clinical.Site data, the most researched conditions in "Maricopa Medical Center" are
"Burns" (3 trials), "HIV Infections" (3 trials), "COVID-19" (2 trials), "Congestive Heart Failure" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Maricopa Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Maricopa Medical Center
Most popular intervention types in "Maricopa Medical Center" are "Drug" (30 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "NexoBrid" (2 trials), "Rifabutin" (2 trials), "Saline" (2 trials) and "A Lean Implementation Strategy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Maricopa Medical Center
The vast majority of trials in "Maricopa Medical Center" are
43 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Maricopa Medical Center
Currently, there are NaN active trials in "Maricopa Medical Center".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in Maricopa Medical Center,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Maricopa Medical Center, 2 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 10 trials that are defined as “Not Applicable".